Lithuania has an ambitious goal to become a leader in the life sciences industry by 2030, with the sector accounting for 5% of the country’s GDP. The conditions for innovation and growth in Lithuania’s life sciences ecosystem will be even more favourable in the autumn when the potential of the sector will be presented to an international audience at Life Sciences Baltics, the leading life sciences event in the Baltics.
“Lithuania has been demonstrating record growth in the life sciences ecosystem for almost a decade – we are among the fastest growing industries in Europe. We’d like to maintain this momentum and attract foreign partners to invest in Lithuanian innovation on a global scale, or to integrate Lithuanian companies, universities and research centres into global supply chains as suppliers and partners. We expect that Life Sciences Baltics will contribute to overall success of Lithuania’s life sciences,” said Romualda Stragienė, Head of Innovation Agency Lithuania, the organiser of Life Sciences Baltics.
Globally, the life sciences industry is entering a period of reflection, with investors looking for new markets, supply chains undergoing transformation, and new collaboration and business models being tested. Meanwhile, global demographics, morbidity rates, and economic shifts continue to dictate a strong need for innovations. According to Life Sciences Baltics team lead Lilita Liaudanskaitė, these trends create a favourable environment for Lithuanian life science companies to find customers abroad and implement projects of global significance.
“By organising the Life Sciences Baltics Forum, we are setting the most ambitious goals – to invite to Lithuania those life science professionals, entrepreneurs, investors, and representatives of universities and research centres, who have the desire and need to connect with the Lithuanian life sciences ecosystem participants. We want to strengthen partnerships and links with those markets that are most relevant for our companies, namely, the USA, Western Europe, and Scandinavia,” said Ms Liaudanskaitė.
According to her, the Lithuanian life sciences industry has grown to such an extent that a foreign partner can count on suppliers in contract research, manufacturing, and clinical trials. Besides, the industry has outstanding competencies in the development of cell and gene therapy, protein technologies, medical devices and diagnostic tools, and interdisciplinary high-technology development using lasers and artificial intelligence.
Life Sciences Baltics, the leading life sciences forum in the Baltic countries, will be organised for the sixth time. The live event returns to Vilnius after a five-year break and will take place on 20-21 September. Life Sciences Baltics aim to act as a platform for life science professionals from all over the world and to provide access to new contacts, ideas, projects and funding opportunities. Innovation Agency Lithuania organises Life Sciences Baltics every two years.
The event consists of an international conference, an exhibition, business meetings and a startup pitch challenge. In September, Life Sciences Baltics is expected to bring together more than 800 life sciences professionals and experts worldwide. Pre-registration for the event and the business exhibition is now open.